Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Cisplatin vs. Gemcitabine/Carboplatin in Advanced NSCLC
NCT00055965Phase 3Unknown
- Sponsor
- The Christie
- Start
- Nov 2002
- Primary completion
- Aug 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, carboplatin in non-small cell lung cancer (NSCLC), sponsored by The Christie. Status: unknown.
02
Drugs
cisplatincarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00055965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055965.